{"symbol": "GLYC", "companyName": "GlycoMimetics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.glycomimetics.com", "description": "GlycoMimetics Inc is a clinical stage biotechnology company. It is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.", "CEO": "Rachel K. King", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}